Free tool
Cell therapy stocks
We cover 3 companies grouped under the Cell therapy theme. The median market value in the group is $482.61M. Across the group, the median move over the past trading day is +0.27%. Price change over the past year runs from +8.7% to +14.5% across the middle 80 percent of the group, with a median of +9.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| SYNC.L | Syncona Limited | 111.40 GBP | +5.69% | +16.65% | +15.68% |
| DTSQ | DT Cloud Star Acquisition Corporation | $11.33 | −0.18% | +4.72% | +8.42% |
| DTSQU | DT Cloud Star Acquisition Corporation | $11.49 | 0.00% | +4.95% | +9.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.